Full Schedule

Lead Speaker: Janick Weberpals, RPh, PhD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA

Speaker: Anna Schultze, PhD, MSc – London School of Hygiene and Tropical Medicine

Speaker: John R. Tazare, PhD – London School of Hygiene and Tropical Medicine

Speaker: Shirley V. Wang, PhD (she/her/hers) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School

Lead Speaker: Sebastian Schneeweiss, MD, ScD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School

Speaker: Jeremy A. Rassen, ScD, FISPE – Aetion

Speaker: Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA

Speaker: Elizabeth M. Garry, PhD, MPH (she/her/hers) – Aetion, Inc.

Lead Speaker: Nancy A. Dreyer, PhD, MPH, FISPE, Fellow DIA (she/her/hers) – Dreyer Strategies LLC

Speaker: Mackenzie Herzog, PhD, MPH – IQVIA

Speaker: William G. Dixon, MD PhD – University of Manchester

Speaker: Kristen A. Hahn, MPH, PhD (she/her/hers) – PicnicHealth

Lead Speaker: Jenny Sun, PhD – Pfizer, Inc.

Speaker: Daniel B. Horton, MD, MSCE (he/him/his) – Rutgers Center for Pharmacoepidemiology and Treatment Science

Speaker: Mehmet Burcu, PhD, MS (he/him/his) – Merck & Co., Inc., Rahway, NJ, United States

Speaker: Jonathan L. Slaughter, MD, MPH – Nationwide Children's Hospital and The Ohio State University

Lead Speaker: Judith C. Maro, PhD – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute

Lead Speaker: Monica A. Muñoz, PharmD, PhD (she/her/hers) – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Speaker: G. Niklas Norén, PhD – Uppsala Monitoring Centre

Speaker: Jens-Ulrich Stegmann

Lead Speaker: Priscilla Velentgas, PhD (she/her/hers) – Merck

Speaker: Cynthia J. Girman, DrPH, FISPE (she/her/hers) – CERobs Consulting, LLC

Speaker: Noelle M. Cocoros, DSc, MPH – Harvard Pilgrim Health Care Institute, Dept. of Population Medicine

Speaker: Sebastian Weis

Lead Speaker: Danica Marinac-Dabic – FDA

Speaker: Katherine Donegan, PhD (she/her/hers) – Medicines and Healthcare products Regulatory Agency

Lead Speaker: Vanessa Didelez, PhD (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS

Speaker: Bianca Kollhorst, PhD (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS

Speaker: Claudia Börnhorst, PhD – Leibniz Institute for Prevention Research and Epidemiology - BIPS

Lead Speaker: Jaclyn L. Bosco, PhD, MPH. FISPE (she/her/hers) – IQVIA

Speaker: Rohini K. Hernandez, PhD MPH (she/her/hers) – Amgen, Inc.

Speaker: Thijs J. Giezen, PhD – Spaarne Gasthuis

Speaker: Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona

Lead Speaker: Michele Jonsson Funk, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill

Speaker: Sudha R. R. Raman, PhD (she/her/hers) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC

Speaker: Mugdha Gokhale, PhD – Pfizer

Speaker: Til Stürmer, MD, PhD (he/him/his) – University of North Carolina at Chapel Hill

Speaker: Jessica C. Young, PhD (she/her/hers) – CAUSALab at IMM, Karolinska Institutet

Lead Speaker: Cindy Ke Zhou, PhD, MBBS (she/her/hers) – Moderna, Inc.

Lead Speaker: Elizabeth J. Bell, PhD, MPH (she/her/hers) – Harvard Pilgrim Health Care Institute

Speaker: Henok Tadesse Ayele, PhD – Merck & Co., Inc.

Speaker: Kaatje Bollaerts, PhD – P95 Epidemiology & Pharmacovigilance

Speaker: Robert T. Chen, MA, MD, FISPE (he/him/his) – Brighton Collaboration

Speaker: Priyadarshani Dharia, PhD, MD, MPH (she/her/hers) – Moderna, Inc.

Speaker: Hector S. Izurieta, MD, PhD – US Food and Drug Administration

Speaker: Katherine E. Mues, PhD, MPH – Aetion, Inc.

Lead Speaker: Mary E. Ritchey, PhD, FISPE – CERobs Consulting

Speaker: Paul Coplan – MedTech Epidemiology & Real-World Data Sciences, Johnson & Johnson

Speaker: Mackenzie Herzog, PhD, MPH – IQVIA

Speaker: Stephen S. Johnston, PhD – Johnson and Johnson

Speaker: David Maislin – Biomedical Statistical Consulting

Speaker: Lisa Weiss, PhD – Healthcare Innovation & Technology Lab

Lead Speaker: Andrea V. Margulis, MD, ScD, FISPE – RTI Health Solutions, Barcelona, Spain

Speaker: Brian T. Bateman, MD, MSc – Stanford University

Speaker: Sonia Hernandez-Diaz, MD, DrPH – Harvard T.H. Chan School of Public Health

Speaker: Krista F. Huybrechts, PhD, MS – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School

Speaker: Leyla Sahin, MD – Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA

Lead Speaker: Emily Bratton, MPH, PhD (she/her/hers) – IQVIA

Speaker: Daniel Rosenberg, PhD – Johnson & Johnson

Speaker: Xabier Garcia de Albeniz Martinez, MD, PhD – RTI Health Solutions

Speaker: Jie J. Li, PhD (she/her/hers) – Office of Surveillance and Epidemiology, CDER, US FDA